| Author |
Message |
samir767
Newbie
Joined: 08/Jul/2010
Location: India
Online Status: Offline
Posts: 24
|
   Topic: How confusing can it get for an investor?
Posted: 21/Jul/2010 at 1:37pm |
How more confusing can it get for an investor!!!
interesting read from the brokerages.
Ranbaxy Labs June qtr PAT seen down at Rs 569.2 cr: Prabhudas Liladhar
Ranbaxy Labs June qtr PAT seen down at Rs 490.1 cr: Karvy
Ranbaxy Labs Jun qtr PAT seen up at Rs 233.9 cr: Emkay
Ranbaxy Labs Jun qtr PAT seen up at Rs 39.9 cr: Motilal Oswal
Buy Ranbaxy Labs; target Rs 792: PINC Research
Reduce Ranbaxy Labs; target of Rs 445: Angel
Sell Ranbaxy, target of Rs 230: HDFC Securities
|
|
Never give up your right to be wrong, because then you will lose the ability to learn new things and move forward with your life--- Dr. David M. Burns
|
 IP Logged |
|
|
|
 |
|
karn
Senior Member
Joined: 05/Apr/2010
Online Status: Offline
Posts: 798
|
Posted: 21/Jul/2010 at 2:43pm |
Samir, Infact the message is very clear. And that is to IGNORE them. 
|
|
“Invert, always invert.”
|
|
IP Logged |
|
|
|
pkumar
Senior Member
Joined: 25/Feb/2010
Location: India
Online Status: Offline
Posts: 135
|
Posted: 21/Jul/2010 at 4:23pm |
Right said Karn
Always follow your conviction for stocks
Edited by pkumar - 22/Jul/2010 at 12:58pm
|
|
IP Logged |
|
|
|
nav_1996
Senior Member
Joined: 08/Sep/2006
Online Status: Offline
Posts: 803
|
Posted: 21/Jul/2010 at 4:36pm |
|
Especially for Pharma companies, no analyst understands them. And their their educational background of MBA, CA etc is further handicap.
|
|
IP Logged |
|
|
|
Circuit
Senior Member
Joined: 14/Jun/2008
Location: India
Online Status: Offline
Posts: 930
|
Posted: 05/Sep/2010 at 5:29pm |
|
Deleted
Edited by Circuit - 05/Sep/2010 at 5:39pm
|
|
Fundamentalists and anticipators may have difficulties with risk control because a trade keeps looking ‘better’ the more it goes against them....Ed Seykota
|
|
IP Logged |
|
|
|
Circuit
Senior Member
Joined: 14/Jun/2008
Location: India
Online Status: Offline
Posts: 930
|
Posted: 05/Sep/2010 at 5:37pm |
|
Deleted
Edited by Circuit - 05/Sep/2010 at 5:39pm
|
|
Fundamentalists and anticipators may have difficulties with risk control because a trade keeps looking ‘better’ the more it goes against them....Ed Seykota
|
|
IP Logged |
|
|
|
JatinMehta
Newbie
Joined: 30/Jul/2010
Location: India
Online Status: Offline
Posts: 3
|
Posted: 07/Oct/2010 at 3:24pm |
The best way to get updated news feeds is through nominal subscription to reputed online brokers. They provide with latest information on brokerage charges, exit and entry loads, regulations etc. with access to insider news of companies and the like, they are well informed and have great due diligence. Investors new into the market must take the necessary aid from professional brokers and then invest. They are equipped with their knowledge bank and are more suitable and safer for a new investor. I would strongly recommend you check with professional online trading broking firm like GEPL that provides ample information and assistance.
|
|
IP Logged |
|
|
|
navtej91
Senior Member
Joined: 15/Jul/2010
Location: India
Online Status: Offline
Posts: 139
|
Posted: 07/Oct/2010 at 4:27pm |
Originally posted by samir767
How more confusing can it get for an investor!!! interesting read from the brokerages.
Ranbaxy Labs June qtr PAT seen down at Rs 569.2 cr: Prabhudas LiladharRanbaxy Labs June qtr PAT seen down at Rs 490.1 cr: KarvyRanbaxy Labs Jun qtr PAT seen up at Rs 233.9 cr: EmkayRanbaxy Labs Jun qtr PAT seen up at Rs 39.9 cr: Motilal Oswal
Buy Ranbaxy Labs; target Rs 792: PINC ResearchReduce Ranbaxy Labs; target of Rs 445: Angel Sell Ranbaxy, target of Rs 230: HDFC Securities |
Its very difficult to believe in individual Qtr. results that is y it is best to avoid them.. THE BROKERAGES JUST DO IT TO STAY IN LIME LIGHT ... maybe we can start a thread wherein we note how each of the brokerage perform wen it come to calculate forward earnings
|
|
IP Logged |
|
|
|
Active Topics
Memberlist
Calendar
Search
Help
Register
Login
